Matthew Sykes
Stock Analyst at Goldman Sachs
(0)
# 3951
Out of 5,240 analysts
216
Total ratings
48.94%
Success rate
-3.60%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Nautilus Biotechnolo... | Downgrades: Sell | 3 2 | 1.91 | -8.38% | 5 | Dec 5, 2024 | |
Maravai LifeSciences | Downgrades: Sell | 7 5 | 4.71 | -9.77% | 10 | Dec 5, 2024 | |
Veracyte | Downgrades: Neutral | 38 37 | 42.56 | -13.06% | 5 | Dec 5, 2024 | |
Bruker | Upgrades: Neutral | 60 60 | 61.96 | -3.16% | 4 | Dec 5, 2024 | |
Guardant Health | Maintains: Strong Buy | 32 36 | 38.75 | -7.1% | 11 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 75 65 | 55.63 | 16.84% | 12 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 280 250 | 198.94 | 25.67% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 54 70 | 76.47 | -8.46% | 10 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 16 14 | 16.09 | -12.99% | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 370 280 | 202.48 | 38.29% | 2 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 125 140 | 169.09 | -17.2% | 12 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 26 35 | 23.53 | 48.75% | 9 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 26 23 | 17.85 | 28.85% | 2 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 290 250 | 176.03 | 42.02% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 225 250 | 240.31 | 4.03% | 4 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 45 55 | 46.12 | 19.25% | 9 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 23 7 | 19.8 | -67.17% | 11 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 24 | 8.67 | 176.82% | 13 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1150 1300 | 1292.96 | 0.54% | 5 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 32 12 | 9.29 | 29.17% | 6 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 7 3 | 1.94 | 28.87% | 3 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 550 640 | 560.54 | 14.18% | 4 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 9 10 | 5.84 | 71.23% | 8 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 17 19 | 15 | 26.67% | 5 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 28 31 | 13.46 | 130.31% | 9 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 23 26 | 21.75 | 19.54% | 5 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 128 145 | 145.52 | -0.36% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 3 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 1 | n/a | n/a | 6 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 120 105 | 121.6 | -13.65% | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 1 1 | n/a | n/a | 8 | Oct 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 1 | n/a | n/a | 2 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 16 18 | n/a | n/a | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 3 1 | n/a | n/a | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 200 175 | n/a | n/a | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 120 60 | n/a | n/a | 4 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 4 | n/a | n/a | 4 | Apr 13, 2022 |